Table 3

Results of logistic regression model with addition of treatment variables

Patient characteristics Odds ratio (95% CI) p value
Non-metropolitanv Metropolitan3-150 1.09 (0.57, 2.07)0.790
Transfer yesv no3-150 1.19 (0.64, 2.21)0.581
Age group
 ⩽600.11 (0.05, 0.25)<0.001
 61–700.14 (0.08, 0.25)<0.001
 >701
Sex (male v female)0.52 (0.33, 0.82)0.006
Pulse
 <801
 80–<1101.69 (0.95, 3.00)0.072
 ⩾1100.87 (0.41, 1.82)0.697
Systolic blood pressure
 <1001.98 (0.99, 3.93)0.052
 100–1801
 >1800.68 (0.34, 1.36)0.270
Raised JVP1.62 (0.88, 2.98)0.120
Lungs basal crepitations1.21 (0.81, 1.81)0.333
Pulmonary oedema1.77 (1.13, 2.76)0.013
Cardiac arrest4.46 (2.07, 9.57)<0.001
ST increase
 Yes3.66 (2.07, 6.47)<0.001
 No1
 Not recorded5.12 (2.29, 11.44)<0.001
ST depression
 Yes1.32 (0.73, 2.39)0.348
 No1
 Not recorded1.48 (0.39, 5.60)0.555
LBBB
 Yes1.18 (0.57, 2.45)0.651
 No1
 Not recorded0.99 (0.50, 1.97)0.972
History
 Previous AMI0.51 (0.26, 0.98)0.043
 Angina or revascularisation1.09 (0.65, 1.84)0.740
 No history1
Diabetes1.40 (0.78, 2.50)0.249
Position
 Anterior1
 Inferior0.73 (0.36, 1.50)0.386
 Other1.47 (0.68, 3.16)0.318
 Not recorded1.44 (0.70, 2.98)0.317
Cardiomegaly0.60 (0.37, 0.98)0.043
Principal symptom precipitating admission
 Chest painv other0.80 (0.43, 1.49)0.476
Reinfarction5.16 (2.92, 9.10)<0.001
Recurrent chest pain0.98 (0.57, 1.71)0.954
Insurance
 Chargeable1
 Veterans affairs non-chargeable2.17 (0.90, 5.27)0.085
 Non-chargeable2.79 (1.47, 5.30)0.002
ACE inhibitor0.41 (0.25, 0.67)0.001
β blocker0.29 (0.17, 0.50)<0.001
Aspirin0.20 (0.13, 0.32)<0.001
Intravenous heparin0.63 (0.34, 1.17)0.140
Intravenous nitrates1.42 (0.86, 2.34)0.161
Thrombolysis1.48 (0.72, 3.02)0.277
  • 3-150 For non-transferred patients the odds ratio (95% CI) was 0.90 (0.48, 1.67) while for transferred patients it was 6.89 (1.01, 46.87).